Citi upgrades Boston Scientific (NYSE: BSX) from Sell to Hold. Price target $14.

Citi analyst says, "We believe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE